Clinical Trial

Effects of Oncological Treatment During Pregnancy on Mother and Child

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 6, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2006-05-25; most recent amendment 2024-03-04.
Trial Details
NCT Number NCT00330447
Lead Sponsor University Hospital, Gasthuisberg
Collaborators: The Netherlands Cancer Institute, Erasmus Medical Center, San Gerardo Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Charles University, Czech Republic
Conditions Cancer, Pregnancy
Enrollment 5,000 participants
Start Date 2005-08
Primary Completion 2025-04 (estimated)
Study Completion 2032-12 (estimated)
Updated on ClinicalTrials.gov 2024-03-06